Federal Circuit resuscitates Snyder’s heart valve patent

A medical device company, St. Jude Medical, part of Abbott Laboratories, failed in its bid to invalidate a patent for an artificial heart valve at the US Court of Appeals for the Federal Circuit yesterday, Thursday, October 15.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

Federal Circuit hands victory to Snyders over heart valve patent

7 October 2021 The US Court of Appeals for the Federal Circuit has held that claims of a patent covering an artificial heart valve were erroneously held to be unpatentable by the US Patent Trial and Appeal Board, in a blow to a medical device company owned by Abbott Laboratories.

Americas

Snyders revives patent claims against St Jude Medical

25 March 2021 Snyders Heart Valve has been successful in reviving patent claims in an on-going dispute against St Jude Medical.

Americas

Philips sues Boston Scientific over cardiac diagnostic patents

3 November 2020 Health technology company Philips has accused Boston Scientific of infringing six patents through the sale of its Polaris guidance system and related medical devices.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Federal Circuit resuscitates Snyder’s heart valve patent

More on this story

Editor's picks

Editor's picks

More features